What have we learned from high-cost hepatitis C medications?

What we’ve learned from the introduction of high-cost hepatitis C drugs should be used for effective stakeholder alignment and the rollout of future curative therapies: The development of Sovaldi, Harvoni and other leading-edge therapies for hepatitis C was driven in large part by payer and patient demands for drugs with proven cure rates. Manufacturers responded… read more

Curant Health Reports 89.7% Real-World Hepatitis C Cure Rates in Co-Infected Patients

Curant Health President and CEO, Patrick Dunham, and Director of Clinical Services, Vickie Andros, discuss our C the Cure program hepatitis c cure rate for co-infected HIV and hepatitis C patients. Access assistance and MTM protocols key to successfully curing hepatitis C in co-infected patients. For a cohort of hepatitis C and HIV co-infected patients, Curant Health reports… read more

Five Technology Improvements the World of Healthcare Needs

When it comes to value-based care, the technology surrounding healthcare information is not at 100%. There is opportunity for improvement in the following ways: More advanced patient facing Health Information Technology (HIT) Advanced HIT tools are now able to pinpoint the gaps in patient information narrowed down to specific moments in care. Not only can… read more

Curant Health Award Recognizes Outstanding Team Member

Tracey Childs, our newest Curant Cares award winner! Congratulations to Tracey Childs, Office Administrator in our Georgia location, for being nominated as our third recipient of the Curant Cares Award! Tracey takes her responsibilities toward our patients and our Curant team members to the next level of helpfulness, assistance and value. Tracey goes above and… read more

The struggle for alignment in the pharmaceutical industry remains. Will Armada 2016 accelerate our drive to value?

Prior to Armada 2015, my colleagues and I spoke about the dire need for greater alignment among all stakeholders in the pharmaceutical industry. While there have been some advancements in this regard over the past 12 months, they are painfully slow and need acceleration. Within their individual silos, manufacturers and payers continue delivering for their… read more

Three Ways the Patient Experience is Changing

There is a change underway in the specialty pharmacy patient experience. First and foremost, the patient and the patient’s direct care team – providers, clinicians and specialists – are focused on putting patient outcomes above anything else. Why? It’s simple: the costs associated with not attaining improved patient outcomes have a domino effect on all players… read more

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or klindsey@curanthealth.com

Menu Title